Author Affiliations: Department of Psychiatry, University of Colorado School of Medicine, Denver (Dr Lazarus; email@example.com); Johns Hopkins University School of Nursing, Baltimore, Maryland (Dr Campbell); and Department of Family and Community Medicine, Saint Louis University, St Louis, Missouri (Dr Schneider).
To the Editor: The study by Dr Klevens and colleagues1 found that an approach limited to computerized screening and intervention did not improve quality of life for female patients who disclosed IPV. The US Preventive Services Task Force (USPSTF) draft recommendation assigned a B rating to support screening for IPV.2
Lazarus J, Campbell J, Schneider FD. Partner Violence Screening and Women’s Quality of Life. JAMA. 2012;308(22):2334-2336. doi:10.1001/jama.2012.14873